Dealmaker’s Diary: Bank on This Cheap Fintech That’s Growing Quickly
After last year’s one-two-three punch of banking blowups… the sector is undervalued by many measures. Add to that the rise of AI… And you get a cheap fintech stock that is quickly growing.
Buy This, Not That: The Buzz on These 5 Beverage Stocks
These alcoholic beverage companies are some of the biggest of the bunch… with huge global brands and good margins. But their debt and small dividends might leave a bad taste in investors’ mouths. Are they BUYs or NOT?
Dealmaker’s Diary: Sit Back and Relax While This Stock Gains 60%
There’s more to this $2 billion furniture maker than meets the eye… and it stands out for Alpesh for two reasons…
Buy This, Not That: Mining for Income and Profits
The commodities sector has seen prices come back down to earth… but these five big miners come with big dividends. Are they BUYs?
Banks Are Teeing Up a New Financial Crisis
Banks are up to their old tricks… Their latest round of financial engineering is poised to create a new crisis… and we’ll be left holding the bag.
Dealmaker’s Diary: Can This Beloved Company Recapture Its Magic?
This stock used to be a dream come true for investors… but has fallen from its highs. A reader wants to know if the company can recapture its former magic.
Investors Are in Love With Blue Chips and Crypto
Can you feel the love? Investors sure can with both the S&P 500 and cryptocurrencies.
Dealmaker’s Diary: A Controversial Shot at 160% Gains
Alpesh takes a purely financial look at a controversial stock. The numbers tell the tale…
After the Crypto Gold Rush… and Fed Fund Follies
What comes next in the crypto market could be even bigger than Bitcoin… and what’s going on with Fed fund futures?
Dealmaker’s Diary: This Healthcare Stock Comes With a Warning
This company is in a high demand, and it operates in a critically important part of the healthcare sector. But Alpesh says it comes with a warning. Watch his video here.